$AETN

AETERNUM HEALTH, INC.

1
1
0

No SEC Form 4 filings for $AETN in the last 30 days.

Med

Aeternum Health Inc.: Aeternum Announces Acquisition of an Option to Acquire 51% of American Renaissance Minerals, Sponsor of the Nkamouna Cobalt-Nickel-Manganese Project in Cameroon

Aeternum Health Inc. (OTC: AETN) said it acquired an option to buy a 51% stake in American Renaissance Minerals (ARM), which is developing Cameroon’s Nkamouna cobalt-nickel-manganese project. ARM is working with Cameroon to secure a new permit. A historical estimate cited 323 million tonnes at 0.21% cobalt, 0.61% nickel and 1.26% manganese.

Aeternum Health Inc.: Aeternum Health Announces Change in Strategy, New Management, and Updates Investors on Progress

Aeternum Health (OTC: AETN) said it will change its name to Aeternum Resources and shift strategy to supply critical minerals in the US. It appointed Paul Mann as President and Executive Chairman and Josua Oosthuizen as CEO. The company raised over $4 million via a promissory note to advance a Nigeria tin and niobium project, targeting commercial production in 1H 2027.

AETERNUM HEALTH, INC. (AETN): Completion of Acquisition or Disposition of Assets

AETERNUM HEALTH, INC. (AETN) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. false 0000764630 0000764630 2026-06-30 2026-06-30 0000764630 dei:FormerAddressMember 2026-06-30 2026-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 1

AETN sentiment & insider activity

Over the past 7 days, alphai's AI scored 2 news stories mentioning AETN (AETERNUM HEALTH, INC.). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.

Recent AETN coverage spans mergers & acquisitions and corporate actions.

What's driving AETN

  • The deal option is a new control pathway for a strategic critical-minerals asset, potentially improving project execution odds and timeline to production.

    finanznachrichten.de · Aug 7, 2026

  • Near-term OTC sentiment and liquidity may swing on the strategy pivot and management changes, but the core value driver is execution toward commercial production in 1H 2027.

    finanznachrichten.de · Aug 4, 2026

  • The filing confirms a completed change of control and business focus, which can drive repricing and liquidity/float expectations.

    SEC EDGAR 8-K · Jul 7, 2026

alphai scores every news story that mentions AETN with an AI model for sentiment and relevance, and aggregates insider trades from AETERNUM HEALTH, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AETN

Score
$AETNMedAI 8/10

Aeternum Health Inc.: Aeternum Announces Acquisition of an Option to Acquire 51% of American Renaissance Minerals, Sponsor of the Nkamouna Cobalt-Nickel-Manganese Project in Cameroon

Aeternum Health Inc. (OTC: AETN) said it acquired an option to buy a 51% stake in American Renaissance Minerals (ARM), which is developing Cameroon’s Nkamouna cobalt-nickel-manganese project. ARM is working with Cameroon to secure a new permit. A historical estimate cited 323 million tonnes at 0.21% cobalt, 0.61% nickel and 1.26% manganese.

Aeternum Health Inc.: Aeternum Health Announces Change in Strategy, New Management, and Updates Investors on Progress

Aeternum Health (OTC: AETN) said it will change its name to Aeternum Resources and shift strategy to supply critical minerals in the US. It appointed Paul Mann as President and Executive Chairman and Josua Oosthuizen as CEO. The company raised over $4 million via a promissory note to advance a Nigeria tin and niobium project, targeting commercial production in 1H 2027.

AETERNUM HEALTH, INC. (AETN): Completion of Acquisition or Disposition of Assets

AETERNUM HEALTH, INC. (AETN) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. false 0000764630 0000764630 2026-06-30 2026-06-30 0000764630 dei:FormerAddressMember 2026-06-30 2026-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 1

Related tickers